Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4,496 | $4,117 | $6,470 | $8,823 |
| - Cash | $577 | $214 | $216 | $45 |
| + Debt | $3,744 | $3,744 | $2,246 | $0 |
| Enterprise Value | $7,663 | $7,647 | $8,500 | $8,777 |
| Revenue | $0 | $0 | $13 | $123 |
| % Growth | – | -100% | -89.8% | – |
| Gross Profit | -$1,021 | -$1,039 | -$1,781 | -$83 |
| % Margin | – | – | -14,245.2% | -67.8% |
| EBITDA | -$913 | -$1,755 | -$2,470 | -$734 |
| % Margin | – | – | -19,763.4% | -598.4% |
| Net Income | -$1,935 | -$2,794 | -$1,712 | -$793 |
| % Margin | – | – | -13,695.1% | -646.5% |
| EPS Diluted | -0.35 | -0.52 | -0.34 | -0.13 |
| % Growth | 32.7% | -52.9% | -161.5% | – |
| Operating Cash Flow | -$641 | -$1,583 | -$2,297 | -$626 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$641 | -$1,583 | -$2,297 | -$626 |